Physicians sort out pros and cons of several new IOLs on the market
Nov 12, 2021 · The 2 newest multifocal IOLs—AcrySof IQ PanOptix (Alcon) and Tecnis Synergy (Johnson + Johnson Vision)—almost guarantee a broader range of vision than EDoF IOLs but not the avoidance of photic phenomena, Sood said. The PanOptix is a trifocal lens with negative spherical aberration on its anterior surface that has diffractive rings in the ...
Ophthalmology Times - Ophthalmology news, articles, and events
November 6th 2024. In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s non-inferiority objectives, treatment schedule, patient outcomes like reduced treatment burden, and anatomical stability.
Alcon reveals final data from Vivity Registry Study which …
Sep 13, 2023 · Alcon has announced final data from its Vivity Registry Study, which monitored real-world patient experiences for up to 12 months post cataract surgery with implantation of either AcrySof IQ Vivity or AcrySof IQ Vivity Toric presbyopia-correcting intraocular lens (PCIOL).
FDA approves pilocarpine hydrochloride ophthalmic solution for ...
Oct 18, 2023 · Orasis Pharmaceuticals announced the FDA has approved pilocarpine hydrochloride ophthalmic solution 0.4% (Qlosi) for the treatment of presbyopia in adults. The company announced it expects to have pilocarpine hydrochloride ophthalmic solution commercially available in the U.S. in the first half of 2024 …
Myths and misconceptions about autologous serum for dry eye
Jun 22, 2020 · Special to Ophthalmology Times® Autologous serum eye drops (ASEDs) have become a mainstay of therapy for certain categories of patients with dry eye and those with underlying immunologic disease or poor epithelial healing.. The logistics of prescribing ASEDs have changed dramatically in the past few years, making their use far more convenient for patients and physicians alike.
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
Aug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Dispelling myths about refractive lens exchange - Ophthalmology …
Sep 7, 2020 · Ninety-nine percent of the responders considered themselves refractive surgeons and 34% had undergone a laser vision correction themselves. Almost 50% of those who underwent laser vision correction were in their 30s, 30% in their 40s, and 22% in their 20s at the time of surgery. Of the survey responders, 8.5% reported having undergone a lens ...
Options for managing the iris after trauma - Ophthalmology Times
Mar 30, 2021 · The reparative steps in this case followed those mentioned previously: creation of a paracentesis opposite the area of prolapse, injection of minimal viscoelastic, and iris sweep. Before any corneal sutures are placed, the iris may prolapse again after the sweep and so placing a few sutures before sweeping may be necessary.
Fluorometholone acetate: More benefit than meets the eye
Dec 11, 2019 · The ability of a drug to penetrate into the ocular tissues is key to controlling inflammation. “All fluorometholones are not the same,” said Beeran Meghpara, MD, and with good reason.Fluorometholone is the active steroid in formulations used to treat ocular inflammation- however, it is what doesn’t meet the eye that makes the difference, i.e., the vehicle.
Breaking down the dorzolamide shortage - Ophthalmology Times
Aug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in a positive ...